Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf7."
+ : H " , "
% |
, |
" |
|
, |
" , |
||
: & & . |
|
||
: H |
|
||
@ |
|
||
12.00 |
H |
, " |
|
" |
|
|
|
12.81 H |
|
||
14.00 |
H , " |
||
14.01 |
H #&$ |
||
14.02 |
H & |
14.74@ " 3 & VITPAK ( )
14.75' ( V % ; , $, 3 )
13.41? 3 , –( & & Crystal .)$# .
& - ( 0,1% 1 6 &, & 7-10 , – / ,/ , 1 3 – 15 , & (
0,25% 2 6 &), 40 , 80 |
/ / ; $# |
|||||
( |
& , |
" ); |
( $ |
|||
), |
; " (3 |
/ / 5-7 ). |
||||
! &$ |
: 2 2 &, |
2 2 |
||||
&, |
|
|
|
" , |
3 |
$# : |
|
"& |
& , |
|
|
"& " . |
|
|
" - " 12 , |
% " - 15. |
" & :
1.*@ ( ) 0,1% 10
2.* V 30 /
3.*6 0,5 100
4.@ 25 , 100 , 150
5.*G ( )
6.* V 40 / , 80 /2
7. * " & , V 5, 10
8.*6 10%, 20% 100 , 500
9.7 V 125 , 250 /2 ,
10. *? |
( |
) ( & ) 0,1%, 0,5%, 1% 1 |
" & & : |
||
|
,- ! : & |
|
/ , & |
: |
1.National Guideline Clearinghouse. Guideline. Eye Injuries. 2005
2.DUODEMECUM Medical Publications. Eye Injuries. 2001
* – , # (% % ) .
|
P |
|
|
||||||||
: 01-001 |
|
|
|
|
|
|
|
|
|
|
|
"$ &: " |
|
|
|
|
|
|
|
|
|
|
|
: |
|
|
|
|
|
|
|
|
|
|
|
& !: |
" |
, " |
|||||||||
, % . |
|
|
|
|
|
|
|
|
|||
' & & ( ): 21 |
|
|
|
|
|
|
|
|
|
||
(: S02.0 " |
|
|
|
|
|
|
|
|
|
||
T06.0 ; |
|
|
" |
" |
|
||||||
|
|
|
|
|
|
||||||
) : 7 $ " & |
% |
||||||||||
" # |
|
|
& ( |
||||||||
). @ |
|
" |
& |
||||||||
|
%$# |
, |
& |
||||||||
& " . |
|
|
|
|
|
|
|||||
$ : |
|
|
|
|
|
|
|
|
|
|
|
&" |
|
$ . |
|||||||||
|
( & ) #$ |
& " |
|||||||||
, |
, " , |
, |
% |
" , " % . @$ $# & # ( ). " " # & " " , # % # . ; "
3 , |
, % . > & |
||||
$ |
, " . |
||||
' "$ &" |
, |
||||
% # . ' &" |
" |
||||
%$ " # . |
|
||||
* : , |
" % , |
||||
% , |
, & & , |
|
|||
. |
|
|
|
|
|
" |
: 3 |
|
|
||
|
|
: |
% |
; & , % (, % " , & , " ); # " .
" & :
1."
2.7 3
3.&$
4.?
5." "
6. < "
7.7
& & % && .
9. HbsAg, Anti-HCV.
" & & :
+ :
" – " . $"" , , " , ," , # & .
: + " |
" # |
. |
|
3 & |
$# |
$ " , % 3 , ,
& . |
|
|
|
|
||
: H " |
|
|
||||
" & |
# |
% % |
||||
" 3 |
% . 3 $ " & |
|||||
#&$ , |
|
|
, |
|||
|
. |
; |
" |
$# |
. |
|
& " |
# & " & |
|||||
% & |
% . |
|
' & " $# & ." #&$ . % % # , & % ( # ) " " " , %% .
% &" " , $#$ " ,, $"$ . ; %
% & |
" " , % |
|
& |
. K |
" |
" % " # " "% # & .
' $, , % # " % ( # ). '" ; "" & ( " #&$ 3 " & " ). ' % & & % " , " &" & .
% " &
% " , |
|
% |
, |
||
(1 |
). |
|
|||
" " |
|
" |
|||
( " , ). , |
|
|
|||
" # # . |
|
|
|
||
& " & |
" |
#&$ |
|||
$# " ", |
|
|
3 . |
@ # 0,3 % # " . > & 1 " & . " & & $ & $ .
" , % & ,%$# . 7 # . ' &" .
" %
( % " , |
& |
% &, |
||
" & ). ' |
" |
% |
||
|
" . % &" |
|||
" " # % &$, |
% |
|||
& |
|
. |
|
|
? , "$# " ,, $"$# % . 3 % 3 &% . # "% "$ & "" ( $ " ) & & % . ) % # &3 & . < " $# # # % " . 3 # ". $ 3 - " &$ " . H #. &$ " && % "% . + %$ % & "; ", $# $ , #$ #( % &$ , #). & "
" |
|
# |
|
, "! " ( $) |
|
||
"; ", "$# % . |
|
|
|
" $ |
|
||
, |
% . |
||
% |
$ |
|
|
" " |
|
"; " " . ' "& % ( ) " $ $# " .%" " . + " &, % & ", "$# " & , % %. ' " & % $ # & " & # $$ " & $ & % ""; ". ; %
, % $ # & " " , %.
' % % , & " %$$ "$ , $#$ & " .
. & $# & (" )& % &
" . , % |
" & , |
|||||||||
% |
|
|
% % |
& |
||||||
& . H " & |
||||||||||
$ |
# &$ |
$" & |
3 3 |
|
||||||
" |
, % $# " , |
|||||||||
% |
$ $. |
|
|
|
|
|
||||
)$# |
3 |
|
|
|
|
|
||||
" . & - |
" |
|
||||||||
|
V |
|||||||||
|
|
&$ |
. |
|||||||
H |
#&$ . ! & |
|||||||||
|
% # " " " $ |
|||||||||
% & # |
& |
" . ; |
||||||||
" & & |
|
|||||||||
& " L6;, |
" |
. %" & ## &$#.
' % %% " ,
|
. ' |
" $ $ |
|
& , |
3 $ & #&$ |
||
. |
& |
" & |
% |
" % " .
' " " ,
, |
, % |
% |
||||||||||
|
|
|
" |
|
% |
|
. ; |
|||||
% |
|
|
" " ", |
" |
" |
|||||||
$ |
|
|
- " |
|
|
% |
||||||
. " |
|
|||||||||||
#&$ , |
|
|||||||||||
, , &- |
|
&$, |
||||||||||
|
" ( , |
). |
|
|
|
|
|
|||||
|
" : |
|
, |
"- |
||||||||
& % , |
" , & " , |
. |
|
|||||||||
1. |
? &$# , $# : 6 50% -2,0 |
2-3 / 8 5-7 . @ - 1 2-3 / 8 5-7 . J 8100 2-3 / 85-7 . @ 2,0 .
2. B / : 400 1-2 / 8 3-5 . + 0,9% - 400 1-2 / 83-5 . $ 400 1 / 8 3-5 . % % 300 .
3." : _ 2 2-3 / 8 3-5 . 6 15% -400
1-2 / . ? & 10% - 100 1-2 / .
4.+ : 7 2,4% -10 2 / 8 5-7 .2 2 / 8 7-10 . / 1 3 / 1 .
5.H " : ? 10% 250 / 8 5-10 . / 10-20 / 8 7-10 . 20% 5 2-3 / 8 7-10 .
6.% : / 0,75 3 / 8 5 .
7." : 7 2 3-4 / 8 5 . 5 2 / 8 3 .
8.% : 0,1-0,2 2 /
" & :
1.*@ V 1% 1
2.J 8
3.*@ 2 , 5
4., , 3 -
5.*+ V
6.* , " , #$# &
7.*_ V 20 /2
8.*6 10%, 20% 100 , 500
9.*? & 5%, 10%, 20%
10.7 2,4% -10 ,
12. , " & V 5, 10 20
13.* V 20% 5
14.*/ 250 , 500 ; V750
15.7 V 125 , 250 /2 ,
16.5
17.* 100 , 200
" & & :
,- ! : % , "
/ , & :
1.6 IV- - «B % " - .+ », 6 , 18-19 $ 2005 ;
2.'., J J, ' " , 6 , 8 73,
2001.
* – , # (% % ) .
P% III-IV
: 02-016
"$ &: " :
& ! : " , % , ,& , ,.
' & & ( ): 9
(: S05.1 H ) :
$ : % : 1 & - , 2 - % , 3 - % , 4 - " & % ( ).
$ ' @: – TN, – ;+, – ;-.
" : , , 3 . G : 3- : , 3 , , , , , 3 , , ,, . , , , , % , " " & . + : % " , & " , " . 0,1 # # &. ' @ & , % & - . 4-: V$& , & & , % , $$ , V$,& . % # # &. ' @ – " # , % & . 3-4" .
" |
: 3 |
|
: & , % , V$& |
, & , "
" & :
1. < #&$ #
2.&
3.H)B
6.;
7.!
8.# "
" & & :
1.7
2.7
3.!
4.B "
6.&$ "
8.B " " &
+ :
& , & , " :0.25% 2 6 & 12 , - 0,1% 2 6 & 12 ; / & V - - 0,5 3 0,5 - 7 ; /
3 1,5 , 7 .; & 0,01 3 &, 12 , "– " .
" - " ., # .
:
+ " , , ,, " % " , , ": @ % @
16.82 H
08.81J
08.82H " $ #
08.83@ $ #
08.84H " $ #
14.74@ " 3
14.90@ " , "
13.19@ & 3
13.713
14.71H ,
12.98" "
14.87@ &
14.72" ( )
14.75 ' |
|
|
|
|
||
|
& , & , " , |
|
||||
(- – 3 ); $# |
/ |
|||||
% : |
/ & V - - 0,5 3 0,5 - 7 , |
|||||
|
|
/ / 7 ; & 1 3 &, 12 ; $ |
||||
– 10 , |
', – 3 , |
|||||
& ( "& ) |
& , " , |
|||||
|
/ / , / – 5,0, |
: |
||||
|
& , " , |
1 3 &, 5 |
|
|||
1 3 &. |
|
|
|
|
||
@ / |
, / 3-5 |
|||||
. |
|
|
|
|
|
|
$ $ ,& & Cristal . ( & 3 ).
& & & 3 & , - V % , $,
. |
|
|
% " |
|
& |
. |
|
|
" - " 10 , |
" - " |
|
16 . |
|
|
" % & .
" & :
1.*@ ( ) 0,1% 10
2.7 V 125 , 250 /2 ,
3.* V 40 / , 80 /2
4.@ 25 , 100 , 150
5.@
6.*? V 5%, 10% 2 , 5
7.*; V 5% 1
8.*/ V 1 (500 )
9.*_ V 20 /2
10. , " & V 5, 10
11.*' 5 , 10
12.* V 30 /
13.*6 0,5 100
" & & :
,- !: % ,, &
/ , & :
1.National Guideline Clearinghouse. Guideline. Eye Injuries. 2005
2.DUODEMECUM Medical Publications. Eye Injuries. 2001
* – , # (% % ) .